SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-036975
Filing Date
2023-10-12
Accepted
2023-10-12 06:08:51
Documents
12
Period of Report
2023-09-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 37136
  Complete submission text file 0001493152-23-036975.txt   211822

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ladx-20230906.xsd EX-101.SCH 3018
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ladx-20230906_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ladx-20230906_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4026
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-15327 | Film No.: 231321668
SIC: 2836 Biological Products, (No Diagnostic Substances)